Supernus Pharmaceuticals Inc (SUPN)
Sales/Maturities of Investments
$57.66M
Quarterly · Period ending: · USD
SUPN Sales/Maturities of Investments
Latest reported$57.66Mperiod ending
Latest reported$57.66Mperiod ending
SUPN Quarterly Sales/Maturities of Investments ($21.11M → $57.66M)
Quarterly Sales/Maturities of Investments
High-resolution chart · PNG
SUPN sales/maturities of investments history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Sales/Maturities of Investments (USD) |
|---|---|
| 57,662,000 | |
| 59,220,000 | |
| 774,917,000 | |
| 468,556,000 | |
| 110,404,000 | |
| 156,201,000 | |
| 132,980,000 | |
| 148,108,000 | |
| 75,450,000 | |
| 142,324,000 | |
| 35,604,000 | |
| 34,784,000 | |
| 60,455,000 | |
| 240,058,000 | |
| 17,550,000 | |
| 52,077,000 | |
| 92,185,000 | |
| 28,927,000 | |
| 377,963,000 | |
| 68,702,000 | |
| 34,265,000 | |
| 49,579,000 | |
| 59,001,000 | |
| 61,485,000 | |
| 204,579,000 | |
| 53,357,000 | |
| 68,703,000 | |
| 88,302,000 | |
| 49,022,000 | |
| 47,143,000 | |
| 34,556,000 | |
| 25,805,000 | |
| 12,123,000 | |
| 7,343,000 | |
| 5,605,000 | |
| 10,633,000 | |
| 7,279,000 | |
| 5,140,000 | |
| 9,426,000 | |
| 6,740,000 | |
| 8,258,000 | |
| 7,400,000 | |
| 3,910,000 | |
| 11,809,000 | |
| 13,131,000 | |
| 8,731,000 | |
| 11,486,000 | |
| 14,894,000 | |
| 17,997,000 | |
| 9,096,000 | |
| 28,140,000 | |
| 23,253,000 | |
| 11,547,000 | |
| 12,866,000 | |
| 32,052,000 | |
| 9,742,000 | |
| 7,381,000 | |
| 293,000 | |
| -22,000 | |
| 10,457,000 | |
| 8,086,000 | |
| 8,349,000 | |
| 13,600,308 | |
| 21,107,441 |